LA JOLLA PHARMACEUTICAL CO·4

Jan 16, 4:05 PM ET

Wellinghoff Darryl 4

4 · LA JOLLA PHARMACEUTICAL CO · Filed Jan 16, 2020

Insider Transaction Report

Form 4
Period: 2020-01-14
Wellinghoff Darryl
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2020-01-14$8.23/sh+3,000$24,6776,545 total

Documents

1 file
  • 4
    wf-form4_157920870416334.xmlPrimary

    FORM 4